Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Melatonin on Oxidative Stress in Levodopa-Treated Parkinson's Disease
NCT07375693Phase 2Enrolling by invitation
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Feb 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in Parkinson's disease (PD), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Feb 2026; status: enrolling by invitation.
02
Drugs
melatonin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07375693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07375693.